Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN104830704A details a recombinant Candida parapsilosis strain producing (R)-phenylethylene glycol with 99.9% ee. Offers cost reduction and supply reliability for pharma intermediates.
Patent CN113387877B details a novel synthesis for Sodium Picosulfate using sulfamic acid, offering superior purity and reduced inorganic residues for pharmaceutical manufacturing.
Novel 4-step route avoids hydrogenation, ensures 100% ee. Ideal for pharma intermediate supply chain optimization and cost reduction.
Patent CN114507230A reveals a green synthesis route for bicyclic pyridone intermediates using citric acid, offering cost reduction and supply chain reliability for API manufacturing.
Patent CN113683496A details a novel synthetic route for Agrimonol B and Pseudoaspidinol, offering cost reduction in API manufacturing through safer reagents and higher yields.
Patent CN104016913A reveals a green amide synthesis method. Offers cost reduction and supply chain reliability for pharma intermediates.
Patent CN116514864A reveals a safer synthesis route for high-purity pharmaceutical intermediates, offering significant supply chain reliability and cost reduction advantages.
Patent CN109456352A details activatable BODIPY synthesis for PDT. Offers high purity, selective activation, and scalable manufacturing for pharmaceutical supply chains.
Patent CN105168205A offers simplified LCZ696 production. Reduces energy and cost while ensuring high purity for pharmaceutical supply chains globally.
Patent CN101880241A reveals a safer one-pot Curtius rearrangement for Candesartan intermediates, offering significant cost reduction and supply chain reliability for API manufacturers.
Patent CN105130808B enables cost reduction in pharmaceutical intermediates manufacturing via stable raw materials and simplified purification for reliable supply chain continuity.
Patent CN103086969B analysis reveals improved bromination efficiency. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Advanced one-step synthesis of Rebamipide via CN103113294A ensures >99.5% purity and 95% yield, offering significant cost reduction and supply reliability for global pharmaceutical manufacturers.
Patent CN105175400A details zinc-based reduction for Afatinib intermediates offering high purity and reduced pollution for pharmaceutical manufacturing supply chains.
Patent CN107032968A reveals green synthesis for 2,3-dichlorobenzaldehyde. Offers high purity, cost reduction in pharmaceutical intermediates manufacturing, and reliable supply chain.
Novel patent CN104230880A enables cost-effective Atorvastatin side chain production. Reliable supplier for pharmaceutical intermediates with scalable green chemistry.
Novel homogeneous phase method for memantine hydrochloride. High yield 69.5%, purity 99.98%. Cost-effective scale-up for pharmaceutical supply chains.
Advanced phase transfer catalysis for isoflavone 7-O-glucosides. Delivers high yields, mild conditions, and scalable production for global supply chains.
Patent CN116396207B reveals cost-effective photo-nickel catalysis for nitrogen heterocycles. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates significantly.
Patent CN109232700B details a high-efficiency altrenogest synthesis avoiding toxic solvents. Discover cost-effective veterinary intermediate manufacturing solutions.